Amplification and over-expression of the AIB1 nuclear receptor co- activator gene in primary gastric cancers

International Journal of Cancer

Volumn 89, Issue 3, 2000, Pages 217-223

  Sakakura, Chouhei ^a   Hagiwara, Akeo ^a   Yasuoka, Rie ^a   Fujita, Yoshifumi ^a   Nakanishi, Masayoshi ^a   Masuda, Kento ^a   Kimura, Akio ^a   Nakamura, Yusuke ^b   Inazawa, Johji ^a,b   Abe, Tatsuo ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; GENE AIBI; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CHROMOSOME 20Q; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

ADULT; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; DISEASE-FREE SURVIVAL; FEMALE; GASTRIC MUCOSA; GENE AMPLIFICATION; GENE EXPRESSION; HISTONE ACETYLTRANSFERASES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0033947716     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000520)89:3<217::AID-IJC2>3.0.CO;2-6     Document Type: Article

References (35)

1. ANZICK, S.L., KONONEN, J., WALKER, R.L., AZORSA, D.O., TANNER, M.M., GUAN, X.Y., SAUTER, G., KALLIONIEMI, O.P., TRENT, J.M. and MELTZER, P.S., AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 277, 965-968 (1997).
2. BISCHOFF, J.R., ANDERSON, L., ZHU, Y., MOSSIE, K., NG, L., SOUZA, B., SCHRYVER, B., FLANAGAN, P., CHAN, C.S.M., NOVOTNY, M., SLAMON, D.J. and PLOWMAN, G.D., A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J., 17, 3052-3065 (1998).
3. CASTLES, C.G., FUQUA, S.A., KLOTZ, D.M. and HILL, S.M., Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res., 53, 5934-5939 (1993).
4. COX, D.R., Regression models and life tables. J. roy. Stat. Assoc., 29, 187-220 (1972).
5. GHADIMI, B.M., SCHROCK, E., WALKER, R.L., WANGSA, D., JAUHO, A., MELTZER, P.S. and RIED, T., Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Amer. J. Pathol., 154, 525-536 (1999).
6. GOTTELAND, M., DESAUTY, G., DELARUE, J.C., LIU, L. and MAY, E., Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues. Mol. cell. Endocrinol., 112, 1-13 (1995).
7. GUAN, X.Y., XU, J., ANZICK, S.L., ZHANG, H., TRENT, J.M. and MELTZER, P.S., Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res., 56, 3446-3450 (1996).
8. HANSTEIN, B., ECKNER, R., DIRENZO, J., HALACHMI, S., LIU, H., SEARCY, B., KUROKAWA, R. and BROWN, M., p300 is a component of an estrogen receptor coactivator complex. Proc. nat. Acad. Sci. (Wash.), 93, 11540-11545 (1996).
9. ISHINO, S., HASHIMOTO, N., FUSHIKI, S., DATE, K., MORI, T., FUJIMOTO, M., NAKAGAWA, Y., UEDA, S., ABE, T. and INAZAWA, J., Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Cancer, 83, 360-366 (1998).
10. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER, Japanese classification of gastric carcinoma (5th ed., 1st English ed.), Kanehara, Tokyo (1995).
11. KALLIONIEMI, A., KALLIONIEMI, O.P., PIPER, J., TANNER, M., STOKKE, T., CHEN, L., SMITH, H.S., PINKEL, D., GRAY, J.W. and WALDMAN, F.M., Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. nat. Acad. Sci. (Wash.), 91, 2156-2160 (1994).
12. KAMEI, Y., Xu, L., HEINZEL, T., TORCHIA, J., KUROKAWA, R., GLOSS, B., LIN, S.C., HEYMAN, R.A., ROSE, D.W., GLASS, C.K. and ROSENFELD, M.G., A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85, 403-414 (1996).
13. KOULLIAS, G.J., KOURAKLIS, G.P., RAFTOPOULOS, I.S., DAVARIS, P.S., PAPADOPOULOS, S.A. and GOLEMATIS, B.C., Increased estrogen receptor and epidermal growth factor receptor gene product co-expression in surgically resected gastric adenocarcinomas. J. surg. Oncol., 63, 166-171 (1996).
14. MATSUI, M., KOJIMA, O., UEHARA, Y. and TAKAHASHI, T., Characterization of estrogen receptor in human gastric cancer. Cancer, 68, 305-308 (1991).
15. McINERNEY, E.M. and 12 OTHERS, Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Develop., 12, 3357-3368 (1998).
16. NAKAYAMA, H., YOKOI, H. and FUJITA, J., Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucl. Acids Res., 25, 4939 (1992).
17. NESSLING, M., SOLINAS-TOLDO, S., WILGENBUS, K.K., BORCHARD, F. and LICHTER, P., Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer, 23, 307-316 (1998).
18. PITTI, R.M. and 17 OTHERS, Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (Lond.), 396, 699-703 (1998).
19. RANZANI, G.N., PELLEGATA, N.S., PREVIDERE, C., SARAGONI, A., VIO, A., MALTONI, M. and AMADORI, D., Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. Cancer Res., 50, 7811-7814 (1990).
20. RIED, T., KNUTZEN, R., STEINBECK, R., BLEGEN, H., SCHROCK, E., HESELMEYER, K., DU MANOIR, S. and AUER, G., Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer, 15, 234-245 (1996).
21. SAKAKURA, C., MORI, T., SAKABE, T., ARIYAMA, Y., SHINOMIYA, T., DATE, K., HAGIWARA, A., YAMAGUCHI, T., TAKAHASHI, T., NAKAMURA, Y., ABE, T. and INAZAWA, J., Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer, 24, 299-305 (1999).
22. SAKAKURA, C., SWEENEY, E.A., SHIRAHAMA, T., HAKOMORI, S. and IGARASHI, Y., Suppression of bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation. FEBS Lett., 379, 177-180 (1996a).
23. SAKAKURA, C. and 14 OTHERS, Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int. J. Cancer, 67, 101-105 (1996b).
24. SAKAKURA, C. and 12 OTHERS, Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc. nat. Acad. Sci. (Wash.), 91, 11723-11727 (1994).
25. SEN, S., ZHOU, H. and WHITE, R.A., A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene, 14, 2195-2200 (1997).
26. STARK, G.R., DEBATISSE, M., GIULOTTO, E. and WAHL, G.M., Recent progress in understanding mechanism of mammalian DNA amplification. Cell, 57, 901-908 (1989).
27. TAHARA, E., Molecular biology of gastric cancer. World. J. Surg., 19, 484-488 (1995).
28. TANNER, M.M., TIRKKONEN, M., KALLIONIEMI, A., HOLLI, K., COLLINS, C., KOWBEL, D., GRAY, J.W., KALLIONIEMI, O. and ISOLA, J., Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implication. Clin. Cancer Res., 54, 1455-1461 (1995).
29. TIRKKONEN, M., TANNER, M., KARHU, R., KALLIONIEMI, A., ISOLA, J. and KALLIONIEMI, O.P., Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer, 21, 177-184 (1998).
30. TORCHIA, J., ROSE, D.W., INOSTROSA, J., KAMEL, Y., WESTIN, S., GLASS, C.K. and ROSENFELD, M.G., The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature (Lond.), 19, 233-240 (1997).
31. VOORTER, C., JOOS, S., BRINGUIER, P.P., VALLINGA, M., PODDIGHE, P., SCHALKEN, J., DU MANOIR, S., RAMAEKERS, F., LICHTER, P. and HOPMAN, A., Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Amer. J. Pathol., 146, 1341-1354 (1995).
32. WAHL, G.M., The importance of circular DNA in mammalian gene amplification. Cancer Res., 49, 1333-1340 (1989).
33. WHELAN, S.L., PARKIN, D.M. and MASUYER, E., (eds). Trends in cancer incidence and mortality. IARC Sci. Publ. 102, IARC. Lyon (1993).
34. WU, C.W., CHANG, Y.F., YEH, T.H., CHANG, T.J., LUI, W.Y., P'ENG, F.K. and CHI, C.W., Steroid hormone receptors in three human gastric cancer cell lines. Digest. Dis. Sci., 39, 2689-2694 (1994).
35. YAO, T.P., KU, G., ZHOU, N., SCULLY, R. and LIVINGSTON, D.M., The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. nat. Acad. Sci. (Wash.), 93, 10626-10631 (1996).